Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $10.37 and last traded at $10.28, with a volume of 165516 shares. The stock had previously closed at $10.32.
Cybin Stock Performance
The business has a 50-day moving average of $10.38 and a 200-day moving average of $4.41. The stock has a market capitalization of $1.49 billion and a price-to-earnings ratio of -41.83.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- The Most Important Warren Buffett Stock for Investors: His Own
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is the Nasdaq? Complete Overview with History
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Investing in the High PE Growth Stocks
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
